Glimycare MV 2mg/500mg/0.3mg Tablet
Marketer
Systemic Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimycare MV 2mg/500mg/0.3mg Tablet
Diabexe Trio 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexe Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, which includes dietary modifications, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimycare MV 2mg/500mg/0.3mg Tablet
No text was provided to rephrase. Please provide the text you would like me to rewrite.
Uses of Glimycare MV 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimycare MV 2mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment duration. Ingest the Glimycare MV 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing. It should be consumed on an empty stomach.
Common Side effects of Glimycare MV 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimycare MV 2mg/500mg/0.3mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimycare MV 2mg/500mg/0.3mg Tablet whole; do not crush, chew, or fracture it. Administer on an empty stomach.
How Glimycare MV 2mg/500mg/0.3mg Tablet works:
Each Glimycare MV tablet (2mg/500mg/0.3mg) combines three distinct anti-diabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimycare MV 2mg/500mg/0.3mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimycare MV 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimycare MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Glimycare MV 2mg/500mg/0.3mg tablets in individuals with kidney impairment carries a significant risk and is best avoided. Medical advice is crucial before use. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimycare MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimycare MV 2mg/500mg/0.3mg Tablet :
Should you forget to take a Glimycare MV 2mg/500mg/0.3mg Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimycare MV 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently